AKT2の活性化変異とヒトの低血糖症
K Hussain1, B Challis, N Rocha
1Clinical and Molecular Genetics Unit, Developmental Endocrinology Research Group, Institute of Child Health, University College London, London WC1N 1EH, UK.
Science (New York, N.Y.)
|October 8, 2011
まとめ
新しいAKT2遺伝子変異により,重度の断食低血糖症と子供の成長に問題が生じます. この発見は,構成信号伝達経路の活性化と全身代謝疾患を関連付け,まれな遺伝疾患に関する新しい洞察を提供している.
科学分野:
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
- 小児内分泌学について
背景:
- 病理的断食低血糖症は,通常,過剰なインスリンまたはグルコース生産に影響する代謝障害によって引き起こされます.
- 原因不明の重発性重度の低血糖症と子供の非対称な成長は,さらなる調査を促した.
研究 の 目的:
- 不対称な成長を持つ3人の無縁の子供における原因不明の断食低血糖症の遺伝的根拠を調査する.
- 観察された代謝および成長異常の基礎にある分子機構を明らかにする.
主な方法:
- AKT2遺伝子の変異を特定するための遺伝子分析.
- 特定された突然変異がAKT2シグナル伝達に与える影響を評価するために,異質細胞での機能研究.
- 罹患児の臨床評価,低血糖症と成長パターンの評価を含む.
主要な成果:
- この3人の子供には,セリン/スレオニンキナーゼAKT2遺伝子のp.Glu17Lysというデノボ変異が共通していた.
- 変異したAKT2タンパク質は,プラズマ膜への構成的徴募を示し,インスリン独立のダウンストリームシグナル伝達につながった.
- この分子欠陥は,観察された重度の断食低血糖症と非対称な成長を説明します.
結論:
- AKT2変異で見られるように,信号伝達経路の構成的,細胞自律的活性化は,全身代謝疾患を引き起こす可能性があります.
- この発見は,病理的な断食低血糖症の遺伝的原因の理解を広げています.
- この研究は,グルコースホメオスタシスと成長調節におけるAKT2シグナル伝達の役割を強調しています.
さらに関連する動画
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
関連する概念動画
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...